Literature DB >> 29769910

Analyzing and strengthening the vaccine safety program in Manitoba.

J M Montalban1, C Ogbuneke2, T Hilderman1,3.   

Abstract

BACKGROUND: The emergence of a novel influenza A virus in 2009 and the rapid introduction of new pandemic vaccines prompted an analysis of the current state of the adverse events following immunization (AEFI) surveillance response in several provinces.
OBJECTIVES: To highlight aspects of the situational analysis of the Manitoba Health, Healthy Living and Seniors (MHHLS's) AEFI surveillance system and to demonstrate how common business techniques could be usefully applied to a provincial vaccine safety monitoring program.
METHOD: Situational analysis of the AEFI surveillance system in Manitoba was developed through a strengths-weaknesses-opportunities-threats (SWOT) analysis and informed by the National Immunization Strategy vaccine safety priorities. Strategy formulation was developed by applying the threats-opportunities-weaknesses-strengths (TOWS) matrix.
RESULTS: Thirteen strategies were formulated that use strengths to either take advantage of opportunities or avoid threats, that exploit opportunities to overcome weaknesses, or that rectify weaknesses to circumvent threats. These strategies entailed the development of various tools and resources, most of which are either actively underway or completed.
CONCLUSION: The SWOT analysis and the TOWS matrix enabled MHHLS to enhance the capacity of its vaccine safety program.

Entities:  

Year:  2014        PMID: 29769910      PMCID: PMC5868590          DOI: 10.14745/ccdr.v40is3a04

Source DB:  PubMed          Journal:  Can Commun Dis Rep        ISSN: 1188-4169


  5 in total

1.  Strategic marketing management for health management: cross impact matrix and TOWS (threats, opportunities, weaknesses, strengths).

Authors:  T Proctor
Journal:  J Manag Med       Date:  2000

2.  Algorithm to assess causality after individual adverse events following immunizations.

Authors:  Neal A Halsey; Kathryn M Edwards; Cornelia L Dekker; Nicola P Klein; Roger Baxter; Philip Larussa; Colin Marchant; Barbara Slade; Claudia Vellozzi
Journal:  Vaccine       Date:  2012-04-14       Impact factor: 3.641

3.  A systematic analysis of influenza vaccine shortage policies.

Authors:  Lori Uscher-Pines; Daniel J Barnett; Jason W Sapsin; David M Bishai; Ran D Balicer
Journal:  Public Health       Date:  2007-09-07       Impact factor: 2.427

4.  Canada's Vaccine Vigilance Working Group.

Authors:  N Ahmadipour; E Toth; B J Law
Journal:  Can Commun Dis Rep       Date:  2014-12-04

5.  SWOT analysis: strengths, weaknesses, opportunities and threats of the Israeli Smallpox Revaccination Program.

Authors:  Michael Huerta; Ran D Balicer; Alex Leventhal
Journal:  Isr Med Assoc J       Date:  2003-01       Impact factor: 0.892

  5 in total
  2 in total

1.  Canada's Vaccine Vigilance Working Group.

Authors:  N Ahmadipour; E Toth; B J Law
Journal:  Can Commun Dis Rep       Date:  2014-12-04

2.  Vaccine vigilance in Canada: Is it as robust as it could be?

Authors:  P Duclos
Journal:  Can Commun Dis Rep       Date:  2014-12-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.